These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11401000)

  • 1. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
    Daniel DG; Potkin SG; Reeves KR; Swift RH; Harrigan EP
    Psychopharmacology (Berl); 2001 May; 155(2):128-34. PubMed ID: 11401000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
    Lesem MD; Zajecka JM; Swift RH; Reeves KR; Harrigan EP
    J Clin Psychiatry; 2001 Jan; 62(1):12-8. PubMed ID: 11235922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
    Mendelowitz AJ
    Ann Clin Psychiatry; 2004; 16(3):145-54. PubMed ID: 15517847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best clinical practice with ziprasidone IM: update after 2 years of experience.
    Zimbroff DL; Allen MH; Battaglia J; Citrome L; Fishkind A; Francis A; Herr DL; Hughes D; Martel M; Preval H; Ross R
    CNS Spectr; 2005 Sep; 10(9):1-15. PubMed ID: 16247923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
    Barak Y; Mazeh D; Plopski I; Baruch Y
    Am J Geriatr Psychiatry; 2006 Jul; 14(7):629-33. PubMed ID: 16816018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders.
    Agid O; Kapur S; Warrington L; Loebel A; Siu C
    Schizophr Res; 2008 Jul; 102(1-3):241-8. PubMed ID: 18495436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial.
    Mautone A; Scarone S;
    Pharmacopsychiatry; 2011 Jul; 44(5):173-8. PubMed ID: 21751127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.
    Daniel DG; Zimbroff DL; Swift RH; Harrigan EP
    Int Clin Psychopharmacol; 2004 Jan; 19(1):9-15. PubMed ID: 15101564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.
    Brook S; Lucey JV; Gunn KP
    J Clin Psychiatry; 2000 Dec; 61(12):933-41. PubMed ID: 11206599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study.
    Preval H; Klotz SG; Southard R; Francis A
    Gen Hosp Psychiatry; 2005; 27(2):140-4. PubMed ID: 15763126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.
    Zhang H; Wang G; Zhao J; Xie S; Xu X; Shi J; Deng H; Li K; Gao C; Wang X; Vanderburg D; Pan S; Tang H; Shu L; Karayal ON
    J Clin Psychopharmacol; 2013 Apr; 33(2):178-85. PubMed ID: 23422376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.
    Tran-Johnson TK; Sack DA; Marcus RN; Auby P; McQuade RD; Oren DA
    J Clin Psychiatry; 2007 Jan; 68(1):111-9. PubMed ID: 17284138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
    Brook S; Walden J; Benattia I; Siu CO; Romano SJ
    Psychopharmacology (Berl); 2005 Apr; 178(4):514-23. PubMed ID: 15650846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular aripiprazole in the acute management of psychomotor agitation.
    De Filippis S; Cuomo I; Lionetto L; Janiri D; Simmaco M; Caloro M; De Persis S; Piazzi G; Simonetti A; Telesforo CL; Sciarretta A; Caccia F; Gentile G; Kotzalidis GD; Girardi P
    Pharmacotherapy; 2013 Jun; 33(6):603-14. PubMed ID: 23505124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
    Baldaçara L; Sanches M; Cordeiro DC; Jackoswski AP
    Braz J Psychiatry; 2011 Mar; 33(1):30-9. PubMed ID: 21537720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.